The peptide regulator Vezusten in the management of overactive bladder syndrome: an efficacy evaluation
Introduction. Overactive bladder (OAB) remains one of the most difficult-to-treat conditions in neurourology. The number of patients seeking help for OAB symptoms does not decrease each year, while a pathogenetic treatment has not yet been developed. This motivates the search for new approaches.Obje...
Saved in:
Main Authors: | G. V. Kovalev, I. A. Labetov, R. R. Shakirova, D. D. Shkarupa |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education
2024-09-01
|
Series: | Вестник урологии |
Subjects: | |
Online Access: | https://www.urovest.ru/jour/article/view/920 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation
by: Mohamed Abdel-Fattah, et al.
Published: (2025-07-01) -
Transvertebral magnetic neuromodulation for the treatment of overactive bladder: 6 months follow-up
by: G V. Kovalev, et al.
Published: (2020-12-01) -
The Impact of Real-world Use of Overactive Bladder Medications on Dementia Risk in Younger Adults
by: Bruce Li, et al.
Published: (2025-08-01) -
Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study
by: Jae Hun Shim, et al.
Published: (2021-04-01) -
Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females
by: Claudia Covarrubias, et al.
Published: (2025-06-01)